This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Yongping Crawford
Associate Director at NGM Biopharmaceuticals


Yongping Crawford is Director, Biologics, at NGM Biopharmaceuticals. She heads the Cell Line Development (CLD) and Engineering group at NGM and is responsible for all internal and outsourcing CLD activities. She also serves as a team lead for several programs including ophthalmology and immune-oncology projects. She and her team have built a proprietary expression platform that offers high yields using a simple 14-day fed-batch and a fast-track timeline. Previously, Yongping was a group leader at Genentech, where she led the effort in developing and implementing a Targeted Integration host for CLD. Yongping received her PhD from University of California, San Francisco, and completed her postdoctoral training at Genentech.

Agenda Sessions

  • Developing a fast-track NGM expression platform for cell line development and multi-gram scale research supply